X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (789) 789
Publication (18) 18
Book Review (10) 10
Magazine Article (3) 3
Conference Proceeding (1) 1
Dissertation (1) 1
Newsletter (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
probucol - therapeutic use (603) 603
humans (544) 544
male (403) 403
probucol (335) 335
animals (288) 288
female (279) 279
middle aged (226) 226
anticholesteremic agents - therapeutic use (191) 191
probucol - pharmacology (162) 162
cholesterol - blood (160) 160
adult (159) 159
antioxidants - therapeutic use (151) 151
hypercholesterolemia - drug therapy (137) 137
aged (130) 130
atherosclerosis (128) 128
index medicus (124) 124
phenols - therapeutic use (124) 124
rats (112) 112
antioxidants (105) 105
pharmacology & pharmacy (105) 105
triglycerides - blood (96) 96
cardiac & cardiovascular systems (91) 91
hyperlipidemias - drug therapy (82) 82
mice (82) 82
rabbits (79) 79
oxidative stress (77) 77
clinical trials as topic (76) 76
low-density-lipoprotein (76) 76
hyperlipoproteinemia type ii - drug therapy (75) 75
cholesterol (71) 71
drug therapy, combination (71) 71
lipids - blood (70) 70
peripheral vascular disease (70) 70
cholesterol, hdl - blood (65) 65
probucol - administration & dosage (65) 65
antioxidants - pharmacology (63) 63
lipoproteins, ldl - blood (62) 62
cholestyramine resin - therapeutic use (60) 60
hypolipidemic agents - therapeutic use (60) 60
time factors (60) 60
lipoproteins - blood (59) 59
arteriosclerosis - drug therapy (58) 58
cholesterol, ldl - blood (55) 55
probucol - adverse effects (53) 53
treatment outcome (53) 53
hypercholesterolemia (51) 51
arteriosclerosis - prevention & control (50) 50
hypercholesterolemia - blood (50) 50
disease models, animal (47) 47
probucol - analogs & derivatives (47) 47
anticholesteremic agents - pharmacology (46) 46
familial hypercholesterolemia (43) 43
heritable hyperlipidemic rabbit (43) 43
coronary disease - prevention & control (42) 42
hyperlipoproteinemia type ii - blood (41) 41
lipoproteins, ldl - metabolism (41) 41
arteriosclerosis - etiology (40) 40
antioxidant (39) 39
biochemistry & molecular biology (39) 39
clofibrate - therapeutic use (39) 39
double-blind method (38) 38
lipids (38) 38
niacin - therapeutic use (38) 38
progression (38) 38
arteriosclerosis - pathology (36) 36
endocrinology & metabolism (36) 36
inflammation (36) 36
lipid peroxidation - drug effects (36) 36
rats, sprague-dawley (36) 36
restenosis (36) 36
lipoproteins, hdl - blood (35) 35
oxidative stress - drug effects (35) 35
colestipol - therapeutic use (33) 33
follow-up studies (33) 33
lovastatin - therapeutic use (33) 33
prospective studies (33) 33
vitamin e - therapeutic use (33) 33
medicine, research & experimental (32) 32
oxidation-reduction (31) 31
vitamin-e (31) 31
cholesterol - metabolism (30) 30
prevention (30) 30
risk factors (30) 30
drug therapy (29) 29
hyperlipidemias - blood (29) 29
medicine, general & internal (29) 29
expression (28) 28
lipoproteins (28) 28
lipid peroxidation (27) 27
lipid-peroxidation (27) 27
diet (26) 26
phenols - pharmacology (26) 26
hydroxymethylglutaryl-coa reductase inhibitors (25) 25
hypercholesterolemia - complications (25) 25
apolipoproteins - blood (24) 24
apoptosis (24) 24
diabetes (24) 24
disease (24) 24
metabolism (24) 24
pravastatin - therapeutic use (24) 24
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (681) 681
Japanese (28) 28
Russian (19) 19
French (14) 14
Portuguese (13) 13
Chinese (11) 11
Spanish (7) 7
Polish (6) 6
German (4) 4
Italian (4) 4
Bulgarian (2) 2
Czech (2) 2
Norwegian (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


British Journal of Nutrition, ISSN 0007-1145, 02/2013, Volume 109, Issue 3, pp. 394 - 401
Plant-based whole foods provide thousands of bioactive metabolites to the human diet that reduce the risk of developing chronic diseases. beta-Caryophyllene... 
β-Caryophyllene | Antioxidants | Hepatic stellate cells | Liver fibrosis | APOPTOSIS | ACID | ROSMARINUS-TOMENTOSUS | MECHANISM | COMPONENTS | SESQUITERPENE | PROLIFERATION | PEROXIDATION | THIOACETAMIDE | NUTRITION & DIETETICS | beta-Caryophyllene | EXPRESSION | Liver - pathology | Sesquiterpenes - metabolism | Rats, Wistar | Antioxidants - metabolism | Probucol - therapeutic use | Hepatic Stellate Cells - metabolism | Sesquiterpenes - administration & dosage | Carbon Tetrachloride Poisoning - prevention & control | Sesquiterpenes - therapeutic use | Probucol - pharmacology | Carbon Tetrachloride Poisoning - metabolism | Liver - drug effects | Arachidonate 5-Lipoxygenase - chemistry | Lipid Peroxidation - drug effects | Female | Flavoring Agents - therapeutic use | Free Radical Scavengers - therapeutic use | alpha-Tocopherol - metabolism | Hepatic Stellate Cells - drug effects | Cell Line | Cell Survival - drug effects | Arachidonate 5-Lipoxygenase - metabolism | Free Radical Scavengers - metabolism | Liver - metabolism | Hepatic Stellate Cells - enzymology | Free Radical Scavengers - administration & dosage | Lipoxygenase Inhibitors - therapeutic use | Rats | Flavoring Agents - metabolism | Antioxidants - pharmacology | Random Allocation | Flavoring Agents - administration & dosage | Carbon Tetrachloride Poisoning - pathology | Lipoxygenase Inhibitors - administration & dosage | alpha-Tocopherol - therapeutic use | Antioxidants - therapeutic use | Animals | Antioxidants - administration & dosage | Lipoxygenase Inhibitors - metabolism | Oxidative Stress - drug effects | Dietary Supplements
Journal Article
Expert Opinion on Pharmacotherapy, ISSN 1465-6566, 10/2014, Volume 15, Issue 15, pp. 2155 - 2171
Introduction: Percutaneous coronary intervention (PCI) with stent implantation has revolutionized the treatment of obstructive coronary artery disease.... 
oral sirolimus | stent | tranilast | restenosis | cilostazol | drug eluting balloon | probucol | Restenosis | Tranilast | Oral sirolimus | Cilostazol | Probucol | Drug eluting balloon | Stent | PROLIFERATOR-ACTIVATED RECEPTORS | TRIPLE ANTIPLATELET THERAPY | DRUG-ELUTING STENT | RANDOMIZED CONTROLLED-TRIAL | NEOINTIMAL TISSUE PROLIFERATION | PHARMACOLOGY & PHARMACY | PACLITAXEL-COATED BALLOON | PLACEBO-CONTROLLED TRIAL | BARE-METAL STENT | TYPE-2 DIABETES-MELLITUS | SERIAL INTRAVASCULAR ULTRASOUND | Vasodilator Agents - therapeutic use | Humans | ortho-Aminobenzoates - therapeutic use | Probucol - therapeutic use | Drug Delivery Systems | Drug-Eluting Stents - adverse effects | Anti-Bacterial Agents - therapeutic use | Tetrazoles - administration & dosage | Anti-Bacterial Agents - chemistry | Platelet Aggregation Inhibitors - administration & dosage | Tubulin Modulators - administration & dosage | Paclitaxel - administration & dosage | Platelet Aggregation Inhibitors - therapeutic use | Coronary Restenosis - etiology | Sirolimus - analogs & derivatives | Sirolimus - therapeutic use | ortho-Aminobenzoates - administration & dosage | Coronary Restenosis - prevention & control | Paclitaxel - therapeutic use | Probucol - administration & dosage | Tubulin Modulators - therapeutic use | Sirolimus - administration & dosage | Antioxidants - therapeutic use | Antioxidants - administration & dosage | Tetrazoles - therapeutic use | Coronary Restenosis - physiopathology | Anti-Bacterial Agents - administration & dosage | Percutaneous Coronary Intervention - adverse effects | Vasodilator Agents - administration & dosage
Journal Article
Journal Article
Circulation, ISSN 0009-7322, 08/2011, Volume 124, Issue 5, pp. 624 - 632
Journal Article
Journal Article
JAMA, ISSN 0098-7484, 04/2007, Volume 297, Issue 15, pp. 1675 - 1682
Journal Article
Journal of Clinical Investigation, ISSN 0021-9738, 12/2011, Volume 121, Issue 12, pp. 4861 - 4869
Oxidative modification of LDL is an early pathological event in the development of atherosclerosis. Oxidation events such as malondialdehyde (MDA) formation... 
ATHEROSCLEROTIC LESIONS | ANTIBODIES | MEDICINE, RESEARCH & EXPERIMENTAL | IMMUNIZATION | PROTEIN | CHOLESTEROL | LDL | MACROPHAGES | LOW-DENSITY-LIPOPROTEIN | OXIDATION-SPECIFIC EPITOPES | PROGRESSION | Recombinant Fusion Proteins - immunology | Temperature | Blood Vessels - metabolism | Humans | Recombinant Fusion Proteins - therapeutic use | Probucol - therapeutic use | Antibodies, Monoclonal - therapeutic use | Green Fluorescent Proteins - genetics | Cholesterol, Dietary - pharmacokinetics | Hypercholesterolemia - drug therapy | Epitopes - immunology | Single-Chain Antibodies - genetics | Hydrazines - analysis | Single-Chain Antibodies - therapeutic use | Zebrafish Proteins - immunology | Hypercholesterolemia - therapy | Lipoproteins, LDL - metabolism | Porphobilinogen - analogs & derivatives | Drug Evaluation, Preclinical | Antibodies, Monoclonal - immunology | Genes, Reporter | Disease Models, Animal | Malondialdehyde - metabolism | Macrophages - ultrastructure | Green Fluorescent Proteins - analysis | Immunoglobulin Fab Fragments - genetics | Oxidation-Reduction | Animals, Genetically Modified | Zebrafish Proteins - metabolism | Malondialdehyde - analogs & derivatives | Porphobilinogen - analysis | Microscopy, Confocal - methods | Zebrafish - growth & development | Zebrafish - genetics | Antibodies, Monoclonal - genetics | Macrophages - metabolism | Animals | Anticholesteremic Agents - therapeutic use | Microscopy, Fluorescence - methods | Malondialdehyde - immunology | Veins - metabolism | Zebrafish - metabolism | Recombinant Fusion Proteins - genetics | Hypercholesterolemia - metabolism | Lipoproteins, LDL - immunology | Single-Chain Antibodies - immunology | Care and treatment | Hypercholesterolemia | Zebra fish | Lipids | Diagnosis | Properties | Diseases | Technical Advance
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 10/2016, Volume 36, Issue 10, pp. 2108 - 2114
Journal Article
Journal Article
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 371, Issue 9626, pp. 1761 - 1768
Journal Article